Exciting developments for new treatment research
In recent years there has, understandably, been a lot of excitement around cutting-edge therapies that target the specific genetic faults underlying inherited sight loss.
Search results
In recent years there has, understandably, been a lot of excitement around cutting-edge therapies that target the specific genetic faults underlying inherited sight loss.
The project aims to develop a cost effective method of examining the entire ABCA4 gene to look for variations that might cause disease.
Retina UK has invested more than £16million into cutting-edge research since the charity was founded in 1976.
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing
Join Research Development Manager, Kate Arkell as she speaks to our latest research grantees about their projects.
James Birtley is a Retina UK supporter and volunteer who is living with retinitis pigmentosa. He is also a scientist with a particular interest in the structure of proteins, the complex molecules that form the building blocks of our bodies.
Thank you to all those who completed our recent Sight Loss Survey – almost 700 of you took the time to share your experiences.
Jenny Dewing is a postdoctoral researcher working on a Retina UK-funded project with Dr Arjuna Ratnayaka at the University of Southampton.